EVERITA Capital Invests in CLINTRIAL to Support the Growth of Clinical Trials in the Czech Republic
Summary
EVERITA Capital invested in CLINTRIAL to support the company’s expansion in clinical trials across the Czech Republic. CLINTRIAL has spent more than two decades building a clinical research center that has run over 100 Phase II, III, and IV trials and enrolled more than 1,000 patients. The company plans to expand capacity, add therapeutic areas, and deepen partnerships with physicians and healthcare institutions. The transaction also brings in new management support from Tomáš Březina as the company targets faster growth and better clinical research execution.
Funding
Amount
-
Total raised
Date
August 31, 2026
Announcement date
Investors
European Investment Fund
Lead investors
Company
clintrial.cz
Funded company
AskAI Classifications
Sectors
No sectors detected
Functions
No functions detected